Discover and read the best of Twitter Threads about #BetaVariant
Most recents (2)
💡BREAKING—CDC study confirms the NIH-Moderna #COVID19 vaccine is more effective against #DeltaVariant hospitalizations than Pfizer-BioNTech or Johnson & Johnson. Vaccine efficacy for Delta🏥—Moderna 95%, Pfizer 80%, J&J 60%. VE also higher in age <74!🧵
cdc.gov/mmwr/volumes/7…
cdc.gov/mmwr/volumes/7…
2) “Overall, VE against COVID-19 hospital- ization was 86%. VE was significantly lower among adults aged ≥75 years (76%) than among those aged 18–74 years (89%) (Table). The difference in VE point estimates between age groups was similar for Pfizer-BioNTech and Moderna vaccines”
3) “Across all ages, VE was significantly higher among Moderna vaccine recipients (95%) than among Pfizer-BioNTech (80%) or Janssen (60%) vaccine recipients.”
[Thread] 1. Glenda Gray, co-lead investigator, #Sisonke:
We now have results to show the #JnJ jab provides significant protection @ the #DeltaVariant in SA.
What is Sisonke?
The Sisonke study used the #JnJ jab to look @ the effectiveness of the jab among SA #HealthWorkers
We now have results to show the #JnJ jab provides significant protection @ the #DeltaVariant in SA.
What is Sisonke?
The Sisonke study used the #JnJ jab to look @ the effectiveness of the jab among SA #HealthWorkers
2. Gray:
1. #Sisonke vaccinated 477 234 #HealthWorkers
2. 122 sites were used to vaccinate health workers
1. #Sisonke vaccinated 477 234 #HealthWorkers
2. 122 sites were used to vaccinate health workers
3. Gray:
#Sisonke researchers used three sets of data to analyse the study's results:
1. 2 sets of data from medical insurers were used and one set of provincial persal data
2. Today Gray is only reporting on two sets of data
#Sisonke researchers used three sets of data to analyse the study's results:
1. 2 sets of data from medical insurers were used and one set of provincial persal data
2. Today Gray is only reporting on two sets of data
